Detalhe da pesquisa
1.
Targeted genomic landscape of metastases compared to primary tumours in clear cell metastatic renal cell carcinoma.
Br J Cancer
; 118(9): 1238-1242, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29674707
2.
The Clinical Presentation, Survival Outcomes, and Management of Patients With Renal Cell Carcinoma and Cardiac Metastasis Without Inferior Vena Cava Involvement: Results From a Pooled Clinical Trial Database and Systematic Review of Reported Cases.
Clin Genitourin Cancer
; 16(2): e327-e333, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29361425
3.
Durable Clinical Benefit in Metastatic Renal Cell Carcinoma Patients Who Discontinue PD-1/PD-L1 Therapy for Immune-Related Adverse Events.
Cancer Immunol Res
; 6(4): 402-408, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29437040
4.
Change in Neutrophil-to-lymphocyte ratio (NLR) in response to immune checkpoint blockade for metastatic renal cell carcinoma.
J Immunother Cancer
; 6(1): 5, 2018 01 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-29353553
5.
Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinoma.
Science
; 359(6377): 801-806, 2018 Feb 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-29301960
6.
Third-line Targeted Therapy in Metastatic Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium.
Eur Urol
; 71(2): 204-209, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27318422